STOCK TITAN

Attovia Therapeutics (ATTO) director reports major preferred conversion and GS trades

(Very High)
(Very Positive)
Form Type
4

Rhea-AI Filing Summary

Attovia Therapeutics, Inc. director Colin Walsh, affiliated with Goldman Sachs entities, reported the automatic conversion of 22,627,105 shares of Series B and C Preferred Stock into common stock on a 9.29-for-1 basis upon the company’s IPO closing on August 6, 2026, with no cash consideration. The resulting common shares are held indirectly through multiple Goldman Sachs-managed investment vehicles, and Walsh disclaims beneficial ownership beyond any pecuniary interest. On August 5–6, 2026, Goldman Sachs & Co. LLC, acting as a market maker, purchased 585,000 ATTO common shares (including 500,000 at $17.00 and 85,000 at $21.00) and sold 105,807 shares around $21–22 per share; any profit recoverable under Section 16(b) will be remitted to Attovia.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Insider WALSH COLIN
Role Director
Bought 585,000 shs ($10.29M)
Sold 105,807 shs ($2.25M)
Approx. gross sale proceeds $2.25M
Type Security Shares Price Value
Conversion Series B Preferred Stock F4, F5, F1, F6, F7, F8 18,181,830 $0.00 $0.00
Conversion Series C Preferred Stock F4, F5, F1, F6, F7, F8 4,445,275 $0.00 $0.00
Conversion Common Stock F4, F5, F1, F6, F7, F8 1,957,134 $0.00 $0.00
Conversion Common Stock F4, F5, F1, F6, F7, F8 478,498 $0.00 $0.00
Purchase Common Stock F4, F1, F2 500,000 $17.00 $8.50M
Purchase Common Stock F1, F2, F3 85,000 $21.00 $1.78M
Sale Common Stock F1, F2, F3 988 $22.03 $22K
Sale Common Stock F1, F2, F3 447 $21.87 $10K
Sale Common Stock F1, F2, F3 1,332 $22.03 $29K
Sale Common Stock F1, F2, F3 200 $22.05 $4K
Sale Common Stock F1, F2, F3 1,556 $22.06 $34K
Sale Common Stock F1, F2, F3 3,402 $22.02 $75K
Sale Common Stock F1, F2, F3 200 $22.10 $4K
Sale Common Stock F1, F2, F3 480 $21.55 $10K
Sale Common Stock F1, F2, F3 100 $22.11 $2K
Sale Common Stock F1, F2, F3 753 $21.97 $17K
Sale Common Stock F1, F2, F3 672 $22.02 $15K
Sale Common Stock F1, F2, F3 6,970 $22.03 $154K
Sale Common Stock F1, F2, F3 400 $22.02 $9K
Sale Common Stock F1, F2, F3 1,180 $21.84 $26K
Sale Common Stock F1, F2, F3 1,040 $22.05 $23K
Sale Common Stock F1, F2, F3 300 $20.84 $6K
Sale Common Stock F1, F2, F3 443 $21.78 $10K
Sale Common Stock F1, F2, F3 200 $22.05 $4K
Sale Common Stock F1, F2, F3 700 $22.07 $15K
Sale Common Stock F1, F2, F3 1,163 $22.19 $26K
Sale Common Stock F1, F2, F3 100 $21.99 $2K
Sale Common Stock F1, F2, F3 6,763 $21.61 $146K
Sale Common Stock F1, F2, F3 76,418 $21.04 $1.61M
Holdings After Transaction: Series B Preferred Stock — 0 shares (Indirect, See Footnote); Series C Preferred Stock — 0 shares (Indirect, See Footnote); Common Stock — 3,020,632 shares (Indirect, See Footnotes)
Footnotes (8)
  1. F1. The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of the Reporting Person's pecuniary interest therein, if any, and this report shall not be deemed an admission that any such Reporting Person is the beneficial owner of, or has any pecuniary interest in, such securities for purposes of Section 16 of the Exchange Act, or for any other purpose.
  2. F2. These transactions in the common stock of the Issuer were effected by Goldman Sachs & Co. LLC ("GS&Co") acting as a market maker in the ordinary course of business. Without conceding market making trades in the ordinary course of business can result in liability under Section 16(b) of the Exchange Act, the amount of profit potentially recoverable by the Issuer from the reported transactions in the event that they were subject to Section 16(b) will be remitted to the Issuer.
  3. F3. GS&Co's transactions in the Issuer's common stock on August 5, 2026 consisted of purchases of a total of 85,000 shares and sales of a total of 105,807 shares.
  4. F4. The previous report on Form 3 reflected an administrative error with respect to the number of shares of common stock issuable upon conversion of the Preferred Stock, which is corrected in this Form 4.
  5. F5. Each share of Series B Preferred Stock and Series C Preferred Stock (the "Preferred Stock") automatically converted into shares of the Issuer's common stock on a 9.29-for-1 basis upon the closing of the Issuer's initial public offering (the "IPO") on August 6, 2026 without payment of consideration. The Preferred Stock has no expiration date.
  6. F6. The Reporting Person is a managing director of GS&Co, a subsidiary of The Goldman Sachs Group Inc. ("GS Group"). GS Group is the direct owner of GS&Co and an indirect owner of Goldman Sachs Asset Management, L.P. ("GSAM LP"). GS&Co is the manager of Broad Street Principal Investments L.L.C. ("BSPI") which directly holds 96,190 shares of common stock purchased in the IPO and 468,565 shares of common stock converted from 3,497,806 shares of Series B Preferred Stock and 855,179 shares of Series C Preferred Stock of the Issuer. GSAM LP is the investment manager of WSLS Offshore Investments, SLP ("WSLS Offshore") which directly holds 131,283 shares of common stock purchased in the IPO and 639,518 shares of common stock converted from 4,773,948 shares of Series B Preferred Stock and 1,167,182 shares of Series C Preferred Stock of the Issuer,... (continued in footnote 7)
  7. F7. (continued from footnote 6)... West Street Life Sciences I, L.P. ("WSLS I") which directly holds 137,708 shares of common stock purchased in the IPO and 670,812 shares of common stock converted from 5,007,564 shares of Series B Preferred Stock and 1,224,299 shares of Series C Preferred Stock of the Issuer, WSLS Emp Offshore Investments, L.P. ("WSLS Emp Offshore") which directly holds 36,927 shares of common stock purchased in the IPO and 179,879 shares of common stock converted from 1,342,794 shares of Series B Preferred Stock and 328,300 shares of Series C Preferred Stock of the Issuer, and WSLS Emp Onshore Investments, L.P. ("WSLS Emp Onshore") which directly holds 97,892 shares of common stock purchased in the IPO and 476,858 shares of common stock converted from 3,559,718 shares of Series B Preferred Stock and 870,315 shares of Series C Preferred Stock of the Issuer,... (continued in footnote 8)
  8. F8. (continued from footnote 7)... GS&Co is a direct subsidiary of GS Group and is the manager of BSPI. WSLS Offshore, WSLS I, WSLS Emp Offshore, and WSLS Emp Onshore are investment vehicles managed by GSAM LP, an indirect subsidiary of GS Group.
Preferred shares converted 22,627,105 shares Series B and C Preferred Stock converted into common on August 6, 2026
Conversion ratio 9.29-for-1 Each preferred share automatically converted into common upon IPO closing
Common from Series B 1,957,134 shares Common stock underlying converted Series B Preferred Stock
Common from Series C 478,498 shares Common stock underlying converted Series C Preferred Stock
Shares purchased 585,000 shares Total ATTO common shares bought in reported trades
Shares sold 105,807 shares Total ATTO common shares sold on August 5, 2026 by GS&Co
IPO purchase block 500,000 shares at $17.00 Indirect purchase of ATTO common on August 6, 2026
Open-market purchase 85,000 shares at $21.00 GS&Co trades in ATTO common on August 5, 2026
Section 16(b) regulatory
"profit potentially recoverable by the Issuer from the reported transactions in the event that they were subject to Section 16(b)"
A federal rule that requires company insiders—like officers, directors and large shareholders—to return any profits made from buying and selling the company’s stock within a six-month window. It matters to investors because it discourages short-term trades that could exploit non-public information and helps protect outside shareholders by creating a simple, enforceable way to recover unfair gains, much like a rule stopping someone from flipping a limited-edition item for quick profit after getting early access.
market maker market
"transactions in the common stock of the Issuer were effected by Goldman Sachs & Co. LLC acting as a market maker in the ordinary course"
A market maker is a firm or individual that stands ready to buy and sell a particular stock or other security throughout the trading day, posting prices at which it will transact so buyers and sellers can trade quickly. Think of it as a shopkeeper who keeps inventory and posts prices to ensure someone can always buy or sell; this reduces delays, narrows price swings, and helps investors execute trades at fairer, more predictable prices.
pecuniary interest financial
"disclaims beneficial ownership of the securities reported herein except to the extent of the Reporting Person's pecuniary interest therein"
automatic conversion financial
"Preferred Stock automatically converted into shares of the Issuer's common stock on a 9.29-for-1 basis upon the closing of the Issuer's initial public offering"
initial public offering financial
"upon the closing of the Issuer's initial public offering on August 6, 2026"
An initial public offering (IPO) is when a private company first sells its shares to the public and becomes a stock-listed company. It matters because it allows the company to raise money from a wide range of investors, helping it grow, while giving early shareholders a way to sell some of their ownership.

FAQ

What did the ATTO Form 4 report for Colin Walsh and Goldman Sachs?

The Form 4 reports automatic conversion of preferred stock into common upon Attovia’s IPO and market-making trades in ATTO shares by Goldman Sachs & Co. LLC, with potential Section 16(b) profits remitted to the company.

How many Attovia (ATTO) preferred shares were converted and at what ratio?

A total of 22,627,105 Series B and C Preferred shares converted into common on a 9.29-for-1 basis upon the August 6, 2026 IPO closing, with no cash paid for the conversion.

What common stock positions arose from the ATTO preferred conversions?

The conversions produced 1,957,134 and 478,498 ATTO common shares from the Series B and C Preferred, respectively, held indirectly through various Goldman Sachs-managed investment vehicles, not directly by Colin Walsh.

What Attovia (ATTO) share purchases did Goldman Sachs make on this Form 4?

Goldman Sachs-related entities purchased 585,000 ATTO shares, including 500,000 shares at $17.00 on August 6, 2026 and 85,000 shares at $21.00 on August 5, 2026, all reported as indirect ownership.

How many Attovia (ATTO) shares were sold and at what prices?

Goldman Sachs & Co. LLC’s market-making activity on August 5, 2026 involved sales totaling 105,807 ATTO shares at prices generally around $21–22 per share, alongside separate purchase trades that same day.

Were the ATTO trades under a Rule 10b5-1 plan according to this filing?

The Rule 10b5-1 checkbox is not marked as a plan, and footnotes describe the trades as ordinary-course market making by Goldman Sachs & Co. LLC, with potential Section 16(b) profits remitted to Attovia.

Does Colin Walsh claim full beneficial ownership of the ATTO shares reported?

No. Colin Walsh disclaims beneficial ownership of the reported securities except for any pecuniary interest, as the shares are held by Goldman Sachs-affiliated entities that manage investments in Attovia common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
WALSH COLIN

(Last)(First)(Middle)
C/O GOLDMAN SACHS GROUP INC.
2OO WEST STREET

(Street)
NEW YORK NEW YORK 10282

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Attovia Therapeutics, Inc. [ ATTO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/05/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/05/2026P85,000A$2185,000ISee Footnotes(1)(2)(3)
Common Stock08/05/2026S988D$22.0384,012ISee Footnotes(1)(2)(3)
Common Stock08/05/2026S447D$21.8783,565ISee Footnotes(1)(2)(3)
Common Stock08/05/2026S1,332D$22.0382,233ISee Footnotes(1)(2)(3)
Common Stock08/05/2026S200D$22.0582,033ISee Footnotes(1)(2)(3)
Common Stock08/05/2026S1,556D$22.0680,477ISee Footnotes(1)(2)(3)
Common Stock08/05/2026S3,402D$22.0277,075ISee Footnotes(1)(2)(3)
Common Stock08/05/2026S200D$22.176,875ISee Footnotes(1)(2)(3)
Common Stock08/05/2026S480D$21.5576,395ISee Footnotes(1)(2)(3)
Common Stock08/05/2026S100D$22.1176,295ISee Footnotes(1)(2)(3)
Common Stock08/05/2026S753D$21.9775,542ISee Footnotes(1)(2)(3)
Common Stock08/05/2026S672D$22.0274,870ISee Footnotes(1)(2)(3)
Common Stock08/05/2026S6,970D$22.0367,900ISee Footnotes(1)(2)(3)
Common Stock08/05/2026S400D$22.0267,500ISee Footnotes(1)(2)(3)
Common Stock08/05/2026S1,180D$21.8466,320ISee Footnotes(1)(2)(3)
Common Stock08/05/2026S1,040D$22.0565,280ISee Footnotes(1)(2)(3)
Common Stock08/05/2026S300D$20.8464,980ISee Footnotes(1)(2)(3)
Common Stock08/05/2026S443D$21.7864,537ISee Footnotes(1)(2)(3)
Common Stock08/05/2026S200D$22.0564,337ISee Footnotes(1)(2)(3)
Common Stock08/05/2026S700D$22.0763,637ISee Footnotes(1)(2)(3)
Common Stock08/05/2026S1,163D$22.1962,474ISee Footnotes(1)(2)(3)
Common Stock08/05/2026S100D$21.9962,374ISee Footnotes(1)(2)(3)
Common Stock08/05/2026S6,763D$21.6155,611ISee Footnotes(1)(2)(3)
Common Stock08/05/2026S76,418D$21.040ISee Footnotes(1)(2)(3)
Common Stock08/06/2026C1,957,134(4)(5)A$02,042,134(4)ISee Footnotes(1)(6)(7)(8)
Common Stock08/06/2026C478,498(4)(5)A$02,520,632(4)ISee Footnotes(1)(6)(7)(8)
Common Stock08/06/2026P500,000A$173,020,632(4)ISee Footnotes(1)(2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Series B Preferred Stock(4)08/06/2026C18,181,830(5) (5) (5)Common Stock1,957,134(4)(5)$00ISee Footnote(1)(6)(7)(8)
Series C Preferred Stock(4)08/06/2026C4,445,275(5) (5) (5)Common Stock478,498(4)(5)$00ISee Footnote(1)(6)(7)(8)
Explanation of Responses:
1. The Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of the Reporting Person's pecuniary interest therein, if any, and this report shall not be deemed an admission that any such Reporting Person is the beneficial owner of, or has any pecuniary interest in, such securities for purposes of Section 16 of the Exchange Act, or for any other purpose.
2. These transactions in the common stock of the Issuer were effected by Goldman Sachs & Co. LLC ("GS&Co") acting as a market maker in the ordinary course of business. Without conceding market making trades in the ordinary course of business can result in liability under Section 16(b) of the Exchange Act, the amount of profit potentially recoverable by the Issuer from the reported transactions in the event that they were subject to Section 16(b) will be remitted to the Issuer.
3. GS&Co's transactions in the Issuer's common stock on August 5, 2026 consisted of purchases of a total of 85,000 shares and sales of a total of 105,807 shares.
4. The previous report on Form 3 reflected an administrative error with respect to the number of shares of common stock issuable upon conversion of the Preferred Stock, which is corrected in this Form 4.
5. Each share of Series B Preferred Stock and Series C Preferred Stock (the "Preferred Stock") automatically converted into shares of the Issuer's common stock on a 9.29-for-1 basis upon the closing of the Issuer's initial public offering (the "IPO") on August 6, 2026 without payment of consideration. The Preferred Stock has no expiration date.
6. The Reporting Person is a managing director of GS&Co, a subsidiary of The Goldman Sachs Group Inc. ("GS Group"). GS Group is the direct owner of GS&Co and an indirect owner of Goldman Sachs Asset Management, L.P. ("GSAM LP"). GS&Co is the manager of Broad Street Principal Investments L.L.C. ("BSPI") which directly holds 96,190 shares of common stock purchased in the IPO and 468,565 shares of common stock converted from 3,497,806 shares of Series B Preferred Stock and 855,179 shares of Series C Preferred Stock of the Issuer. GSAM LP is the investment manager of WSLS Offshore Investments, SLP ("WSLS Offshore") which directly holds 131,283 shares of common stock purchased in the IPO and 639,518 shares of common stock converted from 4,773,948 shares of Series B Preferred Stock and 1,167,182 shares of Series C Preferred Stock of the Issuer,... (continued in footnote 7)
7. (continued from footnote 6)... West Street Life Sciences I, L.P. ("WSLS I") which directly holds 137,708 shares of common stock purchased in the IPO and 670,812 shares of common stock converted from 5,007,564 shares of Series B Preferred Stock and 1,224,299 shares of Series C Preferred Stock of the Issuer, WSLS Emp Offshore Investments, L.P. ("WSLS Emp Offshore") which directly holds 36,927 shares of common stock purchased in the IPO and 179,879 shares of common stock converted from 1,342,794 shares of Series B Preferred Stock and 328,300 shares of Series C Preferred Stock of the Issuer, and WSLS Emp Onshore Investments, L.P. ("WSLS Emp Onshore") which directly holds 97,892 shares of common stock purchased in the IPO and 476,858 shares of common stock converted from 3,559,718 shares of Series B Preferred Stock and 870,315 shares of Series C Preferred Stock of the Issuer,... (continued in footnote 8)
8. (continued from footnote 7)... GS&Co is a direct subsidiary of GS Group and is the manager of BSPI. WSLS Offshore, WSLS I, WSLS Emp Offshore, and WSLS Emp Onshore are investment vehicles managed by GSAM LP, an indirect subsidiary of GS Group.
Remarks:
/s/ Crystal Orgill, Attorney-in-fact08/13/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)